--- title: "5-Amino-1MQ | PepTracker Pro" description: "A small molecule NNMT inhibitor studied for metabolic enhancement and fat cell reduction." lang: en json-ld: | [ { "@context": "https://schema.org", "@type": "Organization", "name": "PepTracker Pro", "url": "https://peptrackerpro.com", "logo": "https://peptrackerpro.com/favicon.png", "description": "Evidence-based educational resource dedicated to improving peptide research literacy.", "contactPoint": { "@type": "ContactPoint", "email": "hello@peptrackerpro.com", "contactType": "customer support" }, "sameAs": [] }, { "@context": "https://schema.org", "@type": "MedicalWebPage", "name": "5-Amino-1MQ", "description": "A small molecule NNMT inhibitor studied for metabolic enhancement and fat cell reduction.", "url": "https://peptrackerpro.com/peptides/5-amino-1mq", "lastReviewed": "2026-06-12", "reviewedBy": { "@type": "Organization", "name": "PepTracker Pro Research Team", "url": "https://peptrackerpro.com" }, "isPartOf": { "@type": "WebSite", "name": "PepTracker Pro", "url": "https://peptrackerpro.com" } }, { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://peptrackerpro.com" }, { "@type": "ListItem", "position": 2, "name": "Peptides", "item": "https://peptrackerpro.com/peptides" }, { "@type": "ListItem", "position": 3, "name": "5-Amino-1MQ", "item": "https://peptrackerpro.com/peptides/5-amino-1mq" } ] }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "People researching NNMT inhibition for metabolism?", "acceptedAnswer": { "@type": "Answer", "text": "5-Amino-1MQ is a research peptide studied in preclinical models. A small molecule NNMT inhibitor studied for metabolic enhancement and fat cell reduction." } }, { "@type": "Question", "name": "Those interested in NAD+ boosting strategies?", "acceptedAnswer": { "@type": "Answer", "text": "5-Amino-1MQ is a research peptide studied in preclinical models. A small molecule NNMT inhibitor studied for metabolic enhancement and fat cell reduction." } }, { "@type": "Question", "name": "Individuals comparing metabolic enhancement compounds?", "acceptedAnswer": { "@type": "Answer", "text": "5-Amino-1MQ is a research peptide studied in preclinical models. A small molecule NNMT inhibitor studied for metabolic enhancement and fat cell reduction." } } ] } ] --- [Skip to main content](#main) **Educational information only.** This site does not provide medical advice. [Read full disclaimer](/disclaimer) [PepTracker Pro](/) [Home](/)[Peptides](/peptides)[Compare](/compare)[Glossary](/glossary)[Blog](/blog)[Calculators](/calculators)[Start Here](/start) [Open the App](https://app.peptrackerpro.com) [Peptides](/peptides)/ 5-Amino-1MQ **Research-only content.** This page is for educational purposes and does not constitute medical advice. [Read full disclaimer →](/research-disclaimer) # 5-Amino-1MQ Low Evidence A small molecule NNMT inhibitor studied for metabolic enhancement and fat cell reduction. Aliases 5-amino-1-methylquinolinium +1 more Evidence Low Evidence Last Updated 2026-06-12 Reading Time 2 min ## Table of Contents 1. [What It Is](#what-it-is) 2. [Why Researchers Study It](#why-researchers-study) 3. [Proposed Mechanisms](#proposed-mechanisms) 4. [Evidence Snapshot](#evidence-snapshot) 5. [Commonly Discussed Benefits](#benefits) 6. [Safety & Cautions](#safety) 7. [Comparisons](#comparisons) 8. [Calculator Tools](#calculator) 9. [Citations](#citations) ## What It Is 5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that sits at the intersection of SAM metabolism, NAD+ biosynthesis, and epigenetic regulation in adipose tissue. While technically not a peptide, it is widely discussed in the peptide research community due to its metabolic applications and availability through peptide-focused suppliers. NNMT methylates nicotinamide — consuming S-adenosylmethionine (SAM) in the process — and its overexpression has been associated with metabolic dysfunction, obesity, and reduced NAD+ availability. By inhibiting NNMT, 5-Amino-1MQ is proposed to increase intracellular NAD+ levels, restore SAM-dependent methylation capacity, and shift adipocyte metabolism toward energy expenditure. A landmark 2018 study demonstrated that 5-Amino-1MQ treatment increased cellular NAD+ levels by up to 40% and improved energy expenditure in adipocytes. In preclinical (mouse) models, administration reduced fat mass, improved glucose tolerance, and increased energy expenditure — even without changes in caloric intake or exercise. Notably, treated animals showed reduced adipocyte size and lower lipid accumulation without affecting lean mass. As of early 2026, no completed large-scale human clinical trials have been published, though early-phase human studies are emerging. The compound remains strictly a research tool and is not FDA-approved for any indication. Also known as: 5-amino-1-methylquinolinium, NNMT inhibitor ## Why Researchers Study It 5-Amino-1MQ targets a fundamentally different metabolic pathway than GLP-1 agonists or other weight-management compounds — NNMT-mediated NAD+ depletion in fat tissue. Its ability to increase NAD+ by 40% and improve energy expenditure without caloric restriction positions it as a mechanistically novel approach to metabolic dysfunction. Researchers are interested in whether NNMT inhibition can complement or synergize with incretin-based therapies. ## Proposed Mechanisms - Inhibits nicotinamide N-methyltransferase (NNMT) in adipose tissue - Increases intracellular NAD+ levels by up to 40% by preventing nicotinamide methylation - Restores S-adenosylmethionine (SAM) availability for epigenetic methylation reactions - Shifts adipocyte metabolism from lipid storage toward energy expenditure - Reduces adipocyte size and lipid accumulation without affecting lean body mass ## Evidence Snapshot Low Evidence Low Medium High Study Type Model Outcome Link In vitro / Animal (mouse) Adipocyte cultures and diet-induced obese mice 40% increase in NAD+ levels; reduced fat mass and improved glucose tolerance without caloric restriction [Source](https://pubmed.ncbi.nlm.nih.gov/29514064/) Preclinical (mouse) High-fat diet obesity model Reduced adipocyte size and lipid accumulation; increased energy expenditure; no effect on lean mass [Source](https://pubmed.ncbi.nlm.nih.gov/) ## Commonly Discussed Benefits [Fat Loss](/benefits/fat-loss)[Metabolism](/benefits/metabolism)[Energy](/benefits/energy) Researching 5-Amino-1MQ ? Track it, set reminders, and keep notes in the free app. [Track in App](https://app.peptrackerpro.com/?add=5-amino-1mq) ## Safety & Cautions - Preclinical data only; no human clinical trials published - Not a peptide — it is a small molecule compound - Long-term safety profile not established - Not FDA-approved - Part of the 2026 'exercise mimetic' research-compound wave (alongside SLU-PP-332 and MOTS-c) marketed direct-to-consumer despite no completed human trials ## Comparisons See how 5-Amino-1MQ compares to related peptides: [5-Amino-1MQ vs AOD-9604](/compare/5-amino-1mq-vs-aod-9604) [5-Amino-1MQ vs MOTS-c](/compare/5-amino-1mq-vs-mots-c) [5-Amino-1MQ vs NAD+](/compare/5-amino-1mq-vs-nad) [5-Amino-1MQ vs SLU-PP-332](/compare/5-amino-1mq-vs-slu-pp-332) ## Calculator Tools Use our research tools to explore dosing and reconstitution data: [Reconstitution Calculator](/calculators) ## Citations 1. \[1\] Neelakantan H. et al. — Selective and membrane-permeable small molecule inhibitors of NNMT. Biochem Pharmacol. 2018 [PubMed](https://pubmed.ncbi.nlm.nih.gov/29514064/) 2. \[2\] 5-Amino-1MQ Research Guide: NNMT Inhibition, Fat Metabolism — SourcePeptides 2026 [PubMed](https://www.sourcepeptides.co/2026/05/24/5-amino-1mq-research-guide-nnmt-inhibition-fat-metabolism-what-studies-show-in-2026/) 3. \[3\] STAT — An obesity drug deep-dive, and peptides move mainstream (June 11, 2026) [PubMed](https://www.statnews.com/2026/06/11/an-obesity-drug-deep-dive-and-peptides-move-mainstream/) ### Keep researching in the app - Log 5-Amino-1MQ to your private tracker - Set a dosing reminder - Compare it side-by-side with your stack [Open PepTracker Pro Free](https://app.peptrackerpro.com/?add=5-amino-1mq) [Browse more peptides](/peptides) ## Related Peptides ### AOD-9604 Medium Evidence A modified fragment of human growth hormone studied for fat metabolism without growth-promoting effects. [Fat Loss](/benefits/fat-loss)[Metabolism](/benefits/metabolism)[Joint Health](/benefits/joint-health) [View Details](/peptides/aod-9604) [\+ Compare](/compare?select=aod-9604)[](https://app.peptrackerpro.com/?add=aod-9604) ### MOTS-c Low Evidence A mitochondrial-derived peptide studied for metabolic regulation, exercise mimetic effects, and longevity. [Metabolism](/benefits/metabolism)[Fat Loss](/benefits/fat-loss)[Longevity](/benefits/longevity)[Muscle Growth](/benefits/muscle-growth)+2 more [View Details](/peptides/mots-c) [\+ Compare](/compare?select=mots-c)[](https://app.peptrackerpro.com/?add=mots-c) ### NAD+ Medium Evidence A coenzyme essential for cellular energy production, studied for anti-aging and metabolic support. [Energy](/benefits/energy)[Longevity](/benefits/longevity)[Anti-Aging](/benefits/anti-aging)[Metabolism](/benefits/metabolism)+1 more [View Details](/peptides/nad) [\+ Compare](/compare?select=nad)[](https://app.peptrackerpro.com/?add=nad) ### SLU-PP-332 Low Evidence A synthetic ERRα/β/γ pan-agonist studied as an 'exercise mimetic' for endurance, fat oxidation, and metabolic health. [endurance](/benefits/endurance)[Fat Loss](/benefits/fat-loss)[Metabolism](/benefits/metabolism)[Energy](/benefits/energy) [View Details](/peptides/slu-pp-332) [\+ Compare](/compare?select=slu-pp-332)[](https://app.peptrackerpro.com/?add=slu-pp-332) [PepTracker Pro](/) Educational peptide information and research tracking tools. Not medical advice. #### Explore - [Peptide Directory](/peptides) - [Compare Peptides](/compare) - [Glossary](/glossary) - [Benefits](/benefits/sleep) #### Learn - [Blog](/blog) - [Calculators](/calculators) - [Start Here](/start) - [About](/about) #### Legal - [Editorial Policy](/editorial-policy) - [Research Disclaimer](/research-disclaimer) - [Disclaimer](/disclaimer) - [Privacy Policy](/privacy) - [Terms of Service](/terms) - [Contact](/contact) © 2026 PepTracker Pro. Educational purposes only. Not medical advice. Always consult a licensed healthcare provider.